GREENWICH LIFESCIENCES, INC.
Cash Flow Statement
| Line Item | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-2.6M | $-2.5M | $-2.7M | $-2.4M | $-1.6M | $-2.1M | $-2.8M | $-2.3M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $594.5K | $594.5K | $594.5K | $594.5K | $594.5K | $594.5K | $594.5K | $759.6K |
| Net Cash from Operating Activities | $-1.0M | $-1.8M | $-2.2M | $-1.8M | $-967.0K | $-1.6M | $-2.2M | $-1.5M |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | — | — | — | — | — | — | — |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | $0 | $0 |
| Net Cash from Financing Activities | $2.8M | $299.1K | — | — | — | — | $0 | $0 |
| Net Change in Cash | $1.7M | $-1.5M | $-2.2M | $-1.8M | $-967.0K | $-1.6M | $-2.2M | $-1.5M |
| Free Cash Flow | — | — | — | — | — | — | — | — |